The Best AI Stock to Own in the World Today is Trading for Just $25

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

Julia G. Butchko net worth and biography

Julia Butchko Biography and Net Worth

Insider of Immunovant

Prior to joining Immunovant, Julia oversaw strategy and operations as Chief of Staff for the $4 billion Immunology and Neuroscience businesses at Lilly. She previously served as Vice President of Lilly’s Oncology Portfolio Management and Clinical Development teams where she was responsible for over 100 global clinical trials, including immune-oncology collaborations with Merck, Bristol-Myers Squibb, and AstraZeneca. Earlier in her career, Julia held significant roles in product development, marketing, manufacturing, and quality.

She holds a B.S. in Chemistry from the State University of New York at Fredonia, a Ph.D. in Chemistry from Pennsylvania State University, and a Business Certificate from Indiana University’s Kelley School of Business.

What is Julia G. Butchko's net worth?: The estimated net worth of Julia G. Butchko is at least $12.27 million as of April 17th, 2024. Dr. Butchko owns 451,627 shares of Immunovant stock worth more than $12,270,706 as of April 28th. This net worth approximation does not reflect any other investments that Dr. Butchko may own. Additionally, Dr. Butchko receives an annual salary of $531,000.00 as Insider at Immunovant. Learn More about Julia G. Butchko's net worth.
How old is Julia G. Butchko?: Dr. Butchko is currently 53 years old. There are 6 older executives and no younger executives at Immunovant. The oldest executive at Immunovant is Dr. William L. Macias M.D., Ph.D., Chief Medical Officer, who is 66 years old. Learn More on Julia G. Butchko's age.
What is Julia G. Butchko's salary?: As the Insider of Immunovant, Inc., Dr. Butchko earns $531,000.00 per year. There are 3 executives that earn more than Dr. Butchko. The highest earning executive at Immunovant is Dr. Peter Salzmann M.B.A., M.D., CEO & Director, who commands a salary of $1,020,000.00 per year. Learn More on Julia G. Butchko's salary.
How do I contact Julia G. Butchko?: The corporate mailing address for Dr. Butchko and other Immunovant executives is 320 WEST 37TH STREET, NEW YORK NY, 10018. Immunovant can also be reached via phone at 917-580-3099 and via email at [email protected]. Learn More on Julia G. Butchko's contact information.
Has Julia G. Butchko been buying or selling shares of Immunovant?: Over the course of the past ninety days, Julia G. Butchko has sold $326,774.44 of Immunovant stock. Most recently, Julia G. Butchko sold 10,115 shares of the business's stock in a transaction on Wednesday, April 17th. The shares were sold at an average price of $29.06, for a transaction totalling $293,941.90. Following the completion of the sale, the insider now directly owns 451,627 shares of the company's stock, valued at $13,124,280.62. Learn More on Julia G. Butchko's trading history.
Who are Immunovant's active insiders?: Immunovant's insider roster includes Peter . (), Eva Barnett (CFO), Julia Butchko (Insider), Douglas Hughes (Director), Mark Levine (Chief Legal Officer and Corporate Secretary), William Macias (Insider), George Migausky (Director), Atul Pande (Director), Peter Salzmann (CEO), and Frank Torti (Director). Learn More on Immunovant's active insiders.
Are insiders buying or selling shares of Immunovant?: During the last twelve months, Immunovant insiders bought shares 1 times. They purchased a total of 1,526,316 shares worth more than $58,000,008.00. During the last twelve months, insiders at the sold shares 33 times. They sold a total of 432,966 shares worth more than $10,713,116.07. The most recent insider tranaction occured on April, 24th when insider Michael Geffner sold 3,261 shares worth more than $94,242.90. Insiders at Immunovant own 4.8% of the company. Learn More about insider trades at Immunovant.
Information on this page was last updated on 4/24/2024.

Julia G. Butchko Insider Trading History at Immunovant

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/17/2024	Sell	10,115	$29.06	$293,941.90	451,627
4/9/2024	Sell	1,053	$31.18	$32,832.54	461,742
1/5/2024	Sell	1,297	$38.59	$50,051.23	409,963
11/22/2023	Sell	3,265	$32.78	$107,026.70	411,260
10/5/2023	Sell	1,735	$36.24	$62,876.40	414,525
7/12/2023	Sell	1,470	$19.73	$29,003.10	428,593
4/18/2023	Sell	1,544	$15.27	$23,576.88	430,063
1/11/2023	Sell	60,490	$16.79	$1,015,627.10	331,419
10/13/2022	Sell	928	$9.18	$8,519.04	391,909
9/28/2022	Sell	535	$4.67	$2,498.45	392,837
8/30/2022	Sell	548	$5.83	$3,194.84	393,372
7/27/2022	Sell	510	$4.27	$2,177.70	281,104
6/29/2022	Sell	460	$4.02	$1,849.20	281,614
5/24/2022	Sell	492	$3.79	$1,864.68	282,074
4/27/2022	Sell	541	$4.72	$2,553.52	282,566
3/24/2022	Sell	6,381	$5.90	$37,647.90	283,107
9/11/2020	Buy	5,000	$38.17	$190,850.00	5,000

Julia G. Butchko Buying and Selling Activity at Immunovant

Immunovant Company Overview

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.

Today's Range

Now: $27.17

$26.97

$27.97

50 Day Range

MA: $32.10

$27.17

$38.36

2 Week Range

Now: $27.17

$15.90

$45.58

Volume

1,414,961 shs

Average Volume

1,003,272 shs

Market Capitalization

$3.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

The Best AI Stock to Own in the World Today is Trading for Just $25

From Banyan Hill Publishing | Ad

See how you can invest alongside him

Julia Butchko Biography and Net Worth

What is Julia G. Butchko's net worth?

How old is Julia G. Butchko?

What is Julia G. Butchko's salary?

How do I contact Julia G. Butchko?

Has Julia G. Butchko been buying or selling shares of Immunovant?

Who are Immunovant's active insiders?

Are insiders buying or selling shares of Immunovant?